General Sessions

Hear from leaders in the field about critical issues and emerging trends affecting pathology and lab medicine today.

Global Access to Healthcare in Times of Change

Dr. Birx

Deborah L. Birx, MD
Wednesday, September 6
4:15 PM – 5:30 PM
Riverside East

Featured Speaker Ambassador Birx will talk about how in an increasingly connected world, putting patients first not only means caring for them in our local communities, it also presents us with a moral obligation to provide care for people in need across the United States and in resource-limited areas around the world.

A world-renowned medical expert and leader in the field of HIV/AIDS, Ambassador Birx is the U.S. Global AIDS Coordinator overseeing the implementation of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the largest commitment by any nation to combat a single disease in history.

The Right Diagnosis Through Advanced Analytics

Dr. Pritchard

Dr. Caligiuri

Colin C. Pritchard, MD, PhD and
Michael A. Caligiuri, MD

Thursday, September 7
11:30 AM – 12:30 PM
Riverside East

In an effort to transition from Volume to Value-Based healthcare, leading diagnostic providers are looking into innovative solutions to combine patients test results with personalized data to deliver actionable predictive insights to improve clinical and quality outcomes. In this session, Colin C. Pritchard, MD, PhD, and Michael A. Caligiuri, MD, will speak to advanced analytics supporting “the right diagnosis”. It promises to be an in-depth discussion of expert experiences and views on the future of personalized care.

Dr. Pritchard is the director of the genetics and solid tumors laboratory at the University of Washington Medical Center that services the Seattle Cancer Care Alliance (SCCA), as well as a UW associate professor of laboratory medicine. Dr. Pritchard’s clinical work focuses on applications of next-generation sequencing gene panels for cancer risk assessment and precision treatment.

Dr. Caligiuri is director of The Ohio State University Comprehensive Cancer Center, chief executive officer of Ohio State’s James Cancer Hospital and Solove Research Institute, and holds the Nationwide Enterprise Foundation Chair in Cancer Research. He is a physician–scientist whose clinical work is focused in leukemia and lymphoma.